| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $616.0M | $450.5M | $373.5M |
| YoY Revenue Growth % | +36.7% | +20.6% | — |
| Gross Profit | $120.6M | $68.3M | — |
| Gross Margin % | 19.6% | 15.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$12.6M | -$34.3M | -$44.7M |
| Operating Margin % | -2.0% | -7.6% | -12.0% |
| Net Income (GAAP) | -$5.6M | -$26.5M | -$38.3M |
| EBITDA (Normalized) | $7.7M | -$21.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $50.5M | $7.2M | $13.2M |
| Capital Expenditures (CapEx) | $25.4M | $16.4M | — |
| Free Cash Flow (FCF) | $25.1M | -$9.2M | $13.2M |
| FCF Margin % | 4.1% | -2.1% | 3.5% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $132.2M | $86.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $129.4M | $127.6M | — |